Last $2.37 USD
Change Today -0.02 / -0.84%
Volume 65.5K
DCTH On Other Exchanges
Symbol
Exchange
DCTH is not on other exchanges.
As of 8:10 PM 08/28/14 All times are local (Market data is delayed by at least 15 minutes).

delcath systems inc (DCTH) Snapshot

Open
$2.35
Previous Close
$2.39
Day High
$2.40
Day Low
$2.32
52 Week High
10/2/13 - $10.56
52 Week Low
08/4/14 - $1.90
Market Cap
22.4M
Average Volume 10 Days
101.1K
EPS TTM
$-2.77
Shares Outstanding
9.5M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for DELCATH SYSTEMS INC (DCTH)

delcath systems inc (DCTH) Related Businessweek News

No Related Businessweek News Found

delcath systems inc (DCTH) Details

Delcath Systems, Inc. operates as a specialty pharmaceutical and medical device company focusing on the field of oncology in the United States and internationally. The company’s proprietary technology enables the administration of high-dose chemotherapy and other therapeutic agents to diseased organs or regions of the body, while controlling the systemic exposure of those agents. It is primarily involved in the development of CHEMOSAT/Melphalan hepatic delivery system that administers concentrated regional chemotherapy to the liver. Delcath Systems, Inc. was founded in 1988 and is headquartered in New York, New York.

delcath systems inc (DCTH) Top Compensated Officers

Interim Co-Chief Executive Officer, Interim C...
Total Annual Compensation: $330.4K
Interim Co-Chief Executive Officer, Interim C...
Total Annual Compensation: $309.6K
Chief Compliance Officer, Executive Vice Pres...
Total Annual Compensation: $330.2K
Executive Vice President of Regulatory Affair...
Total Annual Compensation: $245.6K
Principal Accounting Officer, Vice President ...
Total Annual Compensation: $199.2K
Compensation as of Fiscal Year 2013.

delcath systems inc (DCTH) Key Developments

Delcath Systems, Inc. Revised Cash Utilization Guidance for Remainder of 2014

Delcath Systems, Inc. revised cash utilization guidance for remainder of 2014. The company revised cash utilization guidance lower for the remaining quarters of the year. The company now expects average quarterly cash utilization to be in the range of $4 million to $5 million for the remainder of the year, as compared to the previous guidance of $5 million to $6 million per quarter.

Delcath Systems, Inc. Announces Unaudited Consolidated Earnings Results for the Second Quarter and Six Months Ended June 30, 2014

Delcath Systems, Inc. announced unaudited consolidated earnings results for the second quarter and six months ended June 30, 2014. For the quarter, the company reported total revenue was $251,000. Loss from operations was $5,904,000 compared with $10,587,000 for the same period a year ago. Net loss was $4,600,000 or $0.52 per diluted share compared to $5,482,000 or $0.91 per basic and diluted share for the same period a year ago. Net cash used in operating activities was $4.0 million, a 62% reduction compared to $10.5 million in the comparable period in 2013. The decrease in cash utilization was in part due to a reduction in NDA submission-related costs, and improved organizational and operational efficiencies. For the six months, the company reported total revenue was $561,000 against $381,000 a year ago. Loss from operations was $10,964,000 compared with $20,790,000 for the same period a year ago. Net loss was $9,878,000 or $1.08 per diluted share compared to $18,328,000 or $3.22 per basic and diluted share for the same period a year ago.

Delcath Systems, Inc. to Report Q2, 2014 Results on Aug 06, 2014

Delcath Systems, Inc. announced that they will report Q2, 2014 results on Aug 06, 2014

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
DCTH:US $2.37 USD -0.02

DCTH Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for DCTH.
View Industry Companies
 

Industry Analysis

DCTH

Industry Average

Valuation DCTH Industry Range
No financial data is available for DCTH.
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact DELCATH SYSTEMS INC, please visit www.delcath.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.